Regeneron (REGN) Tops Q2 EPS by 439c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $797.99 --0%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q2 EPS of $12.89, $4.39 better than the analyst estimate of $8.50. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.29 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tapestry (TPR) Tops Q4 EPS by 7c; offers guidance
- SCYNEXIS (SCYX) PT Raised to $33 at Guggenheim
- Pluralsight (PS) Reports Q2 EPS of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
